Last quarter (Q4 2024), CSPC Pharmaceutical Group's total revenue was HK$12.96B, a decrease of -14.15% from the same quarter last year. In Q4, CSPC Pharmaceutical Group's net income was HK$1.33B. See CSPC Pharmaceutical Group’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	HK$ 29.54B	HK$ 31.47B	HK$ 31.59B	HK$ 27.41B	HK$ 23.58B
Gross Profit	HK$ 20.67B	HK$ 22.19B	HK$ 22.73B	HK$ 20.79B	HK$ 17.67B
Operating Expenses	HK$ 15.22B	HK$ 15.19B	HK$ 15.80B	HK$ 14.64B	HK$ 12.53B
Depreciation and Amortization	HK$ 1.36B	HK$ 1.11B	HK$ 1.07B	HK$ 849.47M	HK$ 763.04M
EBITDA	HK$ 7.18B	HK$ 8.59B	HK$ 8.85B	HK$ 7.57B	HK$ 6.80B
Operating Income	HK$ 5.45B	HK$ 7.01B	HK$ 6.93B	HK$ 6.14B	HK$ 5.14B
Other Income/Expenses	HK$ 229.71M	HK$ 388.72M	HK$ 811.55M	HK$ 591.96M	HK$ 904.76M
Pretax Income	HK$ 5.68B	HK$ 7.39B	HK$ 7.74B	HK$ 6.73B	HK$ 6.04B
Net Income	HK$ 4.41B	HK$ 5.88B	HK$ 6.22B	HK$ 5.51B	HK$ 4.88B
Per Share Metrics
Basic EPS	HK$ 0.38	HK$ 0.50	HK$ 0.52	HK$ 0.46	HK$ 0.41
Diluted EPS	HK$ 0.38	HK$ 0.49	HK$ 0.52	HK$ 0.46	HK$ 0.41
Weighted Average Shares Outstanding	11.74B	11.87B	11.92B	11.95B	11.95B
Weighted Average Shares Outstanding (Diluted)	11.74B	11.87B	11.92B	11.95B	11.96B

Currency in HKD

CSPC Pharmaceutical Group Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing